AGAlan Gob

Alan Gob

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alan Gob has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Aatif Qureshi

    Division of Hematology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Canada

    1 shared publication
  • Anahita Mohseni Meybodi

    Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University, London, Canada

    1 shared publication
  • Bekim Sadikovic

    Verspeeten Clinical Genome Centre, London Health Sciences Centre, London, Canada

    1 shared publication
  • Benjamin Chin-Yee

    Schulich School of Medicine and Dentistry, Western University, London, Canada

    1 shared publication
  • Benjamin Hedley

    Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, Western University, London, Canada

    1 shared publication
  • Cyrus C. Hsia

    Schulich School of Medicine & Dentistry, Department of Pathology and Laboratory Medicine, London Health Sciences Centre Western University London Ontario Canada

    1 shared publication

Latest Publications

  • Open Access

    From local change to scholarly contribution: lessons from a scoping review of the gaps and pitfalls of QI reports

    by Erin Spicer, Alan Gob, Kristen A. Bishop, Natasha McIntyre, Mark Goldszmidt

    Background: Quality improvement reports (QIRs) are important for disseminating real-world interventions in healthcare. However, as a relatively new genre of scholarly writing, QIRs vary widely in clarity, methodological rigour and scholarly contribution. Despite the availability of reporting frameworks such as Standards for Quality Improvement Reporting Excellence (SQUIRE) V.2.0, key elements—such as methodological rigour, contextual detail and rationale for interventions—are often under-reported or poorly articulated. This study aimed to (1) identify best practices in publishing QIRs and (2) examine common methodological strengths and weaknesses in project design and execution. Methods: We conducted a scoping review using the six-stage framework by Arksey and O’Malley. A purposeful sample of 71 QIRs published in 2019 across three leading quality improvement (QI) journals— BMJ Quality & Safety, BMJ Open Quality and Joint Commission Journal on Quality and Patient Safety —was analysed. Data extraction was guided by SQUIRE V.2.0 and supplemented by additional best practices. Return-of-findings sessions with QI scholars, journal editors, frontline practitioners and an international QI conference audience refined the findings and ensured practical relevance. Results: Most QIRs described a local problem and intervention but only 22% articulated strong aim statements with measurable targets. Two-thirds referenced a QI methodology but many descriptions of common QI tools lacked rigour. Process and balancing measures were often missing or inadequately justified. While Plan-Do-Study-Act cycles were commonly reported, few met criteria for ‘authenticity’. Data analysis and display methods varied, with several common weaknesses. Discussion sections frequently lacked depth and contextual factors—critical for reproducibility—were inconsistently described. Eight core lessons emerged to support more rigorous, transparent and impactful reporting. Conclusions: As an emerging genre of scholarly communication, many QIRs still fall short in conveying methodological rigour and transferable insights. This review provides practical recommendations, illustrated by strong examples, to help authors and educators improve the clarity and impact of QIRs across healthcare settings.

  • Patient-Centered Genomic Diagnostic Testing for AML: A Quality Improvement Project

    by Jenny M. Ho, Uday Deotare, Aatif Qureshi, Laila Schenkel, Benjamin Chin-Yee, Anahita Mohseni Meybodi, Emilie Lalonde, Lalit Saini, Alan Gob, Selay Lam, et al.

    PURPOSE: The classification of AML and therapeutic options are now largely driven by genetically defined subtypes. Personalization of treatment relies on timely completion and reporting of cytogenetic and molecular tests, creating challenges in clinical practice. We initiated a quality improvement study with the aim to optimize the process for ordering of genomic diagnostic tests and to reduce test turnaround times (TATs). METHODS: A multidisciplinary working group consisting of hematologists, laboratory scientists, technologists, and hematopathologists was formed and identified the following tests as necessary for expedited testing in patients with AML younger than 75 years: next-generation sequencing (NGS) myeloid panel, karyotype analysis, FLT3 PCR, NPM1 PCR, CBFB::MYH11 PCR, and RUNX1::RUNX1T1 PCR, and proposed a reflexive flow cytometry–triggered genomic diagnostic testing algorithm for newly diagnosed AML (ND-AML). We used the model of improvement and implemented three Plan-Do-Study-Act (PDSA) cycles: education and guidelines for management of ND-AML, implementation of the reflex laboratory-triggered diagnostic testing algorithm for ND-AML, and automation of NGS workflow. We assessed compliance with test ordering according to prescribed guidelines and TAT. RESULTS: After PDSA 2, test ordering improved significantly to more than 90% of relevant tests being initiated at AML diagnosis; and TAT was reduced by 27.6% for NGS and by 54.8% for NPM1 PCR. After PDSA 3, TAT for NGS was overall reduced by 63.3% to 11.4 days and within our 14-day target. We were able to also meet our target TAT of 5 days or less for FLT3 and NPM1 PCRs. DISCUSSION: A multidisciplinary approach with shared decision making between hematologists and laboratory practitioners was essential in the development of an algorithm for reflex testing in AML that resulted in improved test ordering and TAT.